Page last updated: 2024-10-16

aminolevulinic acid and Congenital Erythropoietic Porphyria

aminolevulinic acid has been researched along with Congenital Erythropoietic Porphyria in 2 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fergin, P1
Verstraeten, L1
Van Regemorter, N1
Pardou, A1
de Verneuil, H1
Da Silva, V1
Rodesch, F1
Vermeylen, D1
Donner, C1
Noël, JC1
Nordmann, Y1

Reviews

1 review available for aminolevulinic acid and Congenital Erythropoietic Porphyria

ArticleYear
Photodynamic therapy of dermatoses other than non-melanoma skin cancer.
    The Australasian journal of dermatology, 2005, Volume: 46 Suppl 3

    Topics: Administration, Topical; Aminolevulinic Acid; Humans; Keratosis; Photochemotherapy; Photosensitizing

2005

Other Studies

1 other study available for aminolevulinic acid and Congenital Erythropoietic Porphyria

ArticleYear
Biochemical diagnosis of a fatal case of Günther's disease in a newborn with hydrops foetalis.
    European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1993, Volume: 31, Issue:3

    Topics: Aminolevulinic Acid; Erythrocytes; Feces; Humans; Hydrops Fetalis; Infant, Newborn; Infant, Prematur

1993